Latest Fund Strategy News

Celsius Resources appoints Bardin Davis as MD to lead financing efforts for the MCB Copper-Gold Project, extends Final Investment Decision timeline to late 2026, and navigates a complex ownership dispute in the Philippines while raising A$9.3 million.

Genesis Resources progresses environmental work at its Plavica project in North Macedonia while Australian field activities stall due to wet season, reporting a A$401k operating cash outflow and under two quarters of funding.

CurveBeam AI reported stable device orders but faces regulatory delays for FDA and China clearances, while securing a A$4 million investment from WEGO Orthopaedics and advancing clinical collaborations with robotic surgery systems.

Sky Metals has bolstered its cash reserves with a $20.5 million raise, backing a major drilling push at Tallebung and expanding exploration at Doradilla, positioning both projects for significant resource growth and development progress.

Argosy Minerals pushes forward its 12ktpa Rincon Lithium Project in Argentina, nearing DFS completion and securing a key 40MW energy infrastructure agreement amid robust lithium market demand.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Regener8 Resources has secured a binding agreement to acquire the Srebrenica North Project in Bosnia and Herzegovina, complemented by a successful $800,000 placement and a $2.87 million entitlement offer to fund exploration and due diligence.

NEXTDC has launched the retail tranche of its A$1.5 billion fully underwritten entitlement offer at A$12.70 per share, aiming to back accelerated data centre capacity growth amid unprecedented contracted utilisation.

Skin Elements has inked a binding deal to acquire the Mount Ida Gold Project in Western Australia, aiming to boost its gold assets through a planned capital raise. The move signals a pivot towards mining growth alongside its existing biotech ventures.

Alligator Energy has moved into uranium extraction at its Samphire project, reporting initial Field Recovery Trial results that meet or exceed expectations and launching a Bankable Feasibility Study to underpin development.

Radiopharm Theranostics (ASX: RAD) has completed enrolment in its Phase 2b RAD 101 brain metastases imaging trial with interim data showing 90% concordance with MRI, while progressing early-stage trials of therapeutic candidates RAD 202, RV-01, and RAD 402. The company reported a $19.2 million cash balance at quarter end, down from $34.5 million, with a net operating cash outflow of $14.9 million driven by milestone-related R&D and staff costs.

Kinetiko Energy is advancing a staged development strategy to unlock its 6 trillion cubic feet gas resource in South Africa, targeting first revenues within 18 months through a capital-efficient, risk-managed approach.